Shares of Acadia Pharmaceuticals ACAD lost 9.9% on Wednesday after the company announced a disappointing update from a late-stage study of its investigational candidate, intranasal carbetocin (ACP-101 ...

ACADIA Pharmaceuticals (ACAD) has been on many radar screens lately as its share price continues to climb, with the stock up about 46% this year and roughly 61% over the past year. See our latest ...

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...

A high-level overview of ACADIA Pharmaceuticals Inc. (ACAD) stock. View (ACAD) real-time stock price, chart, news, analysis, analyst reviews and more.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock jumped 26.6% to $22.29 on Friday afternoon following a favorable court ruling. What To Know: The U.S. District Court for the District of Delaware upheld ...

In trading on Thursday, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) crossed above their 200 day moving average of $16.68, changing hands as high as $16.82 per share. Acadia Pharmaceuticals Inc ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...